STAT spoke to Medtronic CEO Geoff Martha about the company’s challenges in the diabetes and renal denervation markets, as well as his broader vision for teasing out innovative products.

Medtronic CEO talks latest bets on diabetes, high blood pressure technology

A district court has handed a preliminary injunction to EOFlow, blocking it from selling products developed using proprietary information derived from insulin pump maker Insulet — the decision arriving as Medtronic is slated to pay $738 million to acquire EOFlow.

Ongoing Insulin Pump Litigation Sees Court Hand Injunction to EOFlow

The list of draft documents touches on many topics the agency has discussed over the past year. Lifecycle management and premarket submissions for devices enabled by AI and machine learning top the list of drafts scheduled for publication in the coming ...

FDA prioritizes guidance on AI, cybersecurity, pulse oximeters in stacked schedule for 2024

New rules are coming that would limit emissions of ethylene oxide (EtO), a toxic, colorless gas used to sterilize medical devices. The Environmental Protection Agency is slated to issue a final rule by March, which the agency expects will reduce EtO ...

FDA: ‘We have had a very loud voice’ on EtO

A trial team at Panish | Shea | Boyle | Ravipudi won a $135 million damages verdict for two California men who were sexually abused by their sixth-grade teacher starting in 1996 in a case where the school district was on notice of other child molestation complaints against the teacher years earlier.

A Full Slate of Litigator of the Week Runners-Up and Shout Outs

Insulet has been awarded a preliminary injunction against EOFlow on its insulin patch pump products | Dispute and injunction come ahead of Medtronic’s planned $738m acquisition of EOFlow.

Medtronic’s $738m deal with insulin maker at risk

Executives are faced with a tremendous obligation - to employees, communities, and shareholders - and an unparalleled opportunity. NORTHAMPTON, MA / ACCESSWIRE / October 11, 2023 / Medtronic Torod B. Neptune, Senior Vice President and Chief Communications ...

Medtronic: Transparency, Accountability, Commitment: Three Non-Negotiables for Responsible Business

At AdvaMed’s The MedTech Conference, Cataldo moderated a panel called “Medtech M&A: Trends, Strategies, and Opportunities.” It featured Medtronic CEO Geoff Martha, Zimmer Biomet SVP and Chief Strategy Officer Rachel Ellingson and Smith+Nephew CEO Deepak Nath.

How Medtronic, Zimmer Biomet and Smith+Nephew approach medtech M&A

Ahead of a planned acquisition by Medtronic, it’s not all smooth sailing for EOFlow. The South Korean company makes a waterproof, disposable insulin patch pump that can hold up to 3.5 days ...

Medtronic target EOFlow faces preliminary injunction as Insulet argues trade secrets case

The global wearable medical devices market size is expected to reach a market valuation of US$ 27.29 Billion by 2022, accelerating with a moderate CAGR of 28.1% by 2022 to 2032. The wearable medical devices market is anticipated to be valued at about US$ 73.

Wearable Medical Devices Market is projected to reach US$ 73.48 Billion by 2032 at a CAGR of 28.1% | FMI

A district court has handed a preliminary injunction to EOFlow, blocking it from selling products developed using proprietary information derived from insulin pump maker Insulet — the decision arriving as Medtronic is slated to pay $738 million to ...

Court Grants Injunction Against EOFlow in Ongoing Insulin Pump Litigation

A federal judge has blocked EOFlow, a company that Medtronic plans to acquire, from selling its insulin patch pump.

Insulet wins preliminary injunction against EOFlow in patent suit

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile ...

Eoflow Co Ltd (294090)

Medtronic, which bought Covidien in 2015, announced the impending acquisition of EOFlow Co. Ltd., which makes the EOPatch insulin delivery device, in May 2023. A descriptive analysis of demand ...

Wearable Medical Devices Market Size Growth & Share Analysis by Top Players

Thurgood Marshall College Fund and Medtronic partner to launch the Research & Development Engagement program WASHINGTON, DC / ACCESSWIRE / October 3, 2023 / Thurgood Marshall College Fund (TMCF ...

TMCF and Medtronic Partner To Launch Academic R&D Grants at HBCUs

Dublin, Sept. 26, 2023 (GLOBE NEWSWIRE) -- The "Insulin Patch Pumps Global Market Report 2023" report has been added to ResearchAndMarkets.com's offering. Major players in the insulin patch pumps ...

Major Players in the Insulin Patch Pumps Global Market to 2030 Include Callnovo, Medtronic, Ypsomed, Sanofi and More

The Food and Drug Administration has released a draft plan for how it will drive international harmonization, convergence and reliance among medical device regulatory authorities. In the draft, the FDA outlines the actions it will take to meet MDUFA V ...

FDA shares draft medical device harmonization plan to meet MDUFA V goal

According to a comprehensive research report by Brandessence Market Research (BMRC), "Insulin Pump Market By Product Type, By End

Insulin Pump Market Size is Expected to Reach USD 12.18 Billion by 2028, With a 13.64% CAGR by 2028 | Brandessence Market Research

According to a comprehensive research report by Brandessence Market Research (BMRC), "Insulin Pump Market By Product Type, By End User, Industry Analysis, Trends, And Forecast

Boston Scientific reached an agreement to acquire neuromodulation company Relievant Medsystems for $850 million upfront, the companies announced on Tuesday. Sunnyvale, California-based Relievant makes a nerve ablation system to treat chronic low back pain ...

Boston Scientific to buy back pain treatment company Relievant for $850M

In addition, Medtronic entered into a definitive agreement in May 2023 to acquire EOFlow Co. Ltd., which further expands its Diabetes segment portfolio of products. In the past six months, MDT shares have increased 3.7% against the industry’s decline of ...

Medtronic (MDT) Gets CE Mark Approval for the New Simplera CGM

In addition, Medtronic entered into a definitive agreement in May 2023 to acquire EOFlow Co. Ltd., which further expands its Diabetes segment portfolio of products. In the past six months ...

The Medtronic Smart MDI system is the first to seamlessly integrate real-time CGM with a smart insulin pen powered by an adjustable algorithm that delivers personalized dosing recommendations. The company’s newest all-in-one, disposable Simplera CGM features a simple, two-step insertion process.

EOFlow

In 2021, HackerNoon hosted the first-ever Startup of the Year awards!!

Meet the Winners of Startups in Asia

“The sun ruling both horizons, triumphant in the horizon in his name; the glittering splendor which is in the sun’s disc.”

THE SONG OF THE MOTH

Static site generators are the best way to produce a simple, secure, super fast website.

The simplest static site generator

While network security is a separate and important subset, cybersecurity covers a broader whole in terms of security. 

Network Security vs. Cybersecurity: What's the Difference?

EOPatch(Wearable Insulin Pump) Manufacturer

EOFLOW

eoflow.com

Since 2011

EOFlow's stories on HackerNoon

Meet the Winners of Startups in Asia

THE SONG OF THE MOTH

The simplest static site generator

Network Security vs. Cybersecurity: What's the Difference?

EOFlow's latest news & mentions

Medtronic CEO talks latest bets on diabetes, high blood pressure technology

Ongoing Insulin Pump Litigation Sees Court Hand Injunction to EOFlow

FDA prioritizes guidance on AI, cybersecurity, pulse oximeters in stacked schedule for 2024

FDA: ‘We have had a very loud voice’ on EtO

A Full Slate of Litigator of the Week Runners-Up and Shout Outs

Medtronic’s $738m deal with insulin maker at risk

Medtronic: Transparency, Accountability, Commitment: Three Non-Negotiables for Responsible Business

How Medtronic, Zimmer Biomet and Smith+Nephew approach medtech M&A

Medtronic target EOFlow faces preliminary injunction as Insulet argues trade secrets case

Wearable Medical Devices Market is projected to reach US$ 73.48 Billion by 2032 at a CAGR of 28.1% | FMI

Court Grants Injunction Against EOFlow in Ongoing Insulin Pump Litigation

Insulet wins preliminary injunction against EOFlow in patent suit

Eoflow Co Ltd (294090)

Wearable Medical Devices Market Size Growth & Share Analysis by Top Players

TMCF and Medtronic Partner To Launch Academic R&D Grants at HBCUs

Major Players in the Insulin Patch Pumps Global Market to 2030 Include Callnovo, Medtronic, Ypsomed, Sanofi and More

FDA shares draft medical device harmonization plan to meet MDUFA V goal

Insulin Pump Market Size is Expected to Reach USD 12.18 Billion by 2028, With a 13.64% CAGR by 2028 | Brandessence Market Research

Insulin Pump Market Size is Expected to Reach USD 12.18 Billion by 2028, With a 13.64% CAGR by 2028 | Brandessence Market Research

Boston Scientific to buy back pain treatment company Relievant for $850M

Medtronic (MDT) Gets CE Mark Approval for the New Simplera CGM

Medtronic (MDT) Gets CE Mark Approval for the New Simplera CGM

Medtronic (MDT) Gets CE Mark Approval for the New Simplera CGM

Medtronic (MDT) Gets CE Mark Approval for the New Simplera CGM

Representing this company? Click here to claim and customize this page!

Reviews About EOFlow

EOFlow WIKI

Apply to get your Tech Company News Page live on HackerNoon.com today!

Light-Mode

Classic

Newspaper

Dark-Mode

Neon Noir

Minty

HN StartUps